Sartorius Stedim Biotech Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,968	2,780	2,776	3,493	2,887
Revenue Growth (YoY)	6.74%	0.16%	-20.53%	20.98%	51.14%
Cost of Revenue	1,622	1,573	1,542	1,675	1,334
Gross Profit	1,345	1,207	1,234	1,817	1,553
Selling, General & Admin	662.7	650.1	617.6	612.3	531.9
Research & Development	133.1	144.1	129.5	132.4	110.5
Other Operating Expenses	11.4	16.5	17.5	18.2	-9.6
Operating Expenses	807.2	810.7	764.6	762.9	632.8
Operating Income	538.1	396	469.4	1,054	920.2
Interest Expense	-138.1	-148	-115.4	-18.2	-10.2
Interest & Investment Income	11.6	18.9	6.2	0.5	0.3
Earnings From Equity Investments	-2.2	-8.6	-	-	-
Currency Exchange Gain (Loss)	-7.3	6.6	-13.3	-32.8	12.3
Other Non Operating Income (Expenses)	-16.1	-12.9	-4.3	-4.6	-37.1
EBT Excluding Unusual Items	386	252	342.6	999.3	885.5
Merger & Restructuring Charges	-	-	-	-	-20.3
Other Unusual Items	-12.8	-32.8	59.3	131.1	-218.5
Pretax Income	373.2	219.2	401.9	1,130	646.7
Income Tax Expense	107.3	40.7	89.2	250.5	232.4
Earnings From Continuing Operations	265.9	178.5	312.7	879.9	414.3
Minority Interest in Earnings	-0.3	-3.4	-2.4	-3.8	0.1
Net Income	265.6	175.1	310.3	876.1	414.4
Net Income to Common	265.6	175.1	310.3	876.1	414.4
Net Income Growth	51.69%	-43.57%	-64.58%	111.41%	23.36%
Shares Outstanding (Basic)	97	97	92	92	92
Shares Outstanding (Diluted)	97	97	92	92	92
Shares Change (YoY)	0.54%	5.01%	-0.00%	-0.01%	-0.00%
EPS (Basic)	2.73	1.81	3.37	9.51	4.50
EPS (Diluted)	2.73	1.81	3.37	9.51	4.50
EPS Growth	50.88%	-46.26%	-64.58%	111.45%	23.51%
Free Cash Flow	299	475.3	272.8	181.7	377.9
Free Cash Flow Per Share	3.07	4.91	2.96	1.97	4.10
Dividend Per Share	0.690	0.690	0.690	1.440	1.260
Dividend Growth	-	-	-52.08%	14.29%	85.29%
Gross Margin	45.33%	43.41%	44.46%	52.03%	53.79%
Operating Margin	18.13%	14.24%	16.91%	30.19%	31.87%
Profit Margin	8.95%	6.30%	11.18%	25.08%	14.35%
Free Cash Flow Margin	10.08%	17.10%	9.83%	5.20%	13.09%
EBITDA	778.1	629.3	657.7	1,197	1,031
EBITDA Margin	26.22%	22.64%	23.70%	34.27%	35.73%
D&A For EBITDA	240	233.3	188.3	142.5	111.2
EBIT	538.1	396	469.4	1,054	920.2
EBIT Margin	18.13%	14.24%	16.91%	30.19%	31.87%
Effective Tax Rate	28.75%	18.57%	22.20%	22.16%	35.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.